Janna Clark-Deuel
Family · Tucson, AZNPI 1700267432
Payments from drug & device makers
Across 55 payments — averaging $49.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$400
- AstraZeneca$385
- Novo Nordisk$342
- GSK$267
- AbbVie$212
- Boston Scientific$129
- plus $995 from 18 others
What the payments were for
- Food & beverage$2,730100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 9 | $400 |
| AstraZeneca | 4 | $385 |
| Novo Nordisk | 4 | $342 |
| GSK | 6 | $267 |
| AbbVie | 3 | $212 |
| Boston Scientific | 2 | $129 |
| Silk Road Medical, Inc. | 1 | $128 |
| Genentech USA, Inc. | 1 | $125 |
| Boehringer Ingelheim | 1 | $117 |
| Nevro Corp. | 1 | $104 |
| Angiodynamics, Inc. | 1 | $89 |
| Amgen | 4 | $75 |
| Sanofi Pasteur Inc. | 3 | $60 |
| Acella Pharmaceuticals, LLC | 1 | $56 |
| Idorsia Pharmaceuticals US Inc | 3 | $44 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| Lilly USA, LLC | 2 | $27 |
| Sunovion Pharmaceuticals Inc. | 1 | $27 |
| Viiv Healthcare Company | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Exact Sciences | 1 | $17 |
| Astellas Pharma US Inc | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MitraClip$150
- ENROUTE Transcarotid Stent$128
- ENROUTE Transcarotid Neuroprotection System$128
- Ozempic$125
- FASENRA$125
- XOLAIR$125
- TEZSPIRE$125
- LOKELMA$125
- UBRELVY$125
- SHINGRIX$122
- JARDIANCE$117
- WATCHMAN Access System$107
- Omnia$104
How this compares
$2,730 in reported general payments places this provider in the 85th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 55 | $448 |
| Rosuvastatin Calcium | 29 | $367 |
| Amlodipine Besylate | 37 | $360 |
| Levothyroxine Sodium | 45 | $359 |
| Lisinopril | 40 | $345 |
| Metformin Hcl | 29 | $252 |
| Losartan Potassium | 14 | $171 |
| Simvastatin | 14 | $154 |
| Escitalopram Oxalate | 12 | $103 |
| Metoprolol Succinate | 13 | $102 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 13 | $69 |
| Hydrochlorothiazide | 11 | $65 |
Paid to pharmacies, not to this prescriber.
Other family in Tucson
- Lindsay CarterTucson$108K
- Vicki McIntyreTucson$68K
- Amber KemnitzTucson$33K
- Joy BaynesTucson$30K
- Cynthia CarstenTucson$27K
- Sharon MorganTucson$22K
- Margaret SpencerTucson$19K
- Polina SamoylovaTucson$18K
- Stephanie Niemi-OlsonTucson$15K
- Cindy ChangTucson$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.